MiddleBrook launches first Pulsys formulation, Moxatag

MiddleBrook Pharmaceuticals has launched Moxatag, the first once-daily amoxicillin tablet to be marketed in the US, more than a year after it was approved by the FDA.

MiddleBrook Pharmaceuticals has launched Moxatag, the first once-daily amoxicillin tablet to be marketed in the US, more than a year after it was approved by the FDA.

Moxatag is also the first product to use the company's Pulsys drug-release technology.

More from Archive

More from Scrip